Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC157 vs BPC-157: Research Application Comparison

Researchers frequently ask whether studies citing "BPC-157" apply to products labeled "BPC157". The answer is yes, provided both refer to the same salt form and purity grade. The table below clarifies which variables actually affect research reproducibility. A

This comparison does not assign a generated winner or score.

  • Researchers frequently ask whether studies citing "BPC-157" apply to products labeled "BPC157". The answer is yes, provided both refer to the same salt form and purity grade. The table below clarifies which variables actually affect research reproducibility.
  • Amino acid sequence
  • Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
  • Zero. Sequence identical
  • Hyphen is typographical only
  • Molecular weight
  • 1419.53 Da
  • Zero. Mass identical
  • No structural difference
  • CAS registry number
  • 137525-51-0 (arginate form)
  • Zero. Same compound
  • Both designations reference same registry entry
  • Salt form variability
  • Arginate or acetate (must verify COA)
  • High. Affects stability and solubility
  • Name alone does not specify salt form
  • Purity specification
  • Requires HPLC verification (target >98%)
  • High. Impurities alter dosing accuracy
  • Name alone does not guarantee purity
  • Reconstitution protocol
  • 2–3 mL bacteriostatic water per 5 mg
  • Zero. Protocol determined by mass, not name
  • Dosing based on peptide mass, not nomenclature
  • The only distinctions that matter for experimental reproducibility. Salt form, purity percentage, and synthesis quality. Are independent of whether the supplier includes a hyphen in the product name. Published studies citing BPC-157 with a hyphen used the same peptide as current suppliers listing BPC157 without one, assuming both sources provide arginate salt forms synthesized to pharmaceutical-grade purity standards.
More references

Related material